Shekhar is Vice President of Regulatory Affairs (EU and International) at Dyne Therapeutics, a Boston-based company specializing in rare muscle diseases. With over 25 years of pharmaceutical and biotech experience in Quality and Regulatory Affairs, he is widely recognized for his industry expertise. Shekhar holds Fellowships with the Royal Society of Chemistry (FRSC) and The Organisation for Professionals in Regulatory Affairs (FTORPA). He serves on the Expert Advisory Group of the British Pharmacopoeia Commission (2024) and the International Rare Disease Research Consortium’s Regulatory Convergence Task Force, contributing to high-profile engagements with the EMA, European Commission, and Indian Ministry of Health.